Overall NARI gets a fundamental rating of 4 out of 10. We evaluated NARI against 184 industry peers in the Health Care Equipment & Supplies industry. NARI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NARI is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.27% | ||
| ROE | -18.07% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 86.82% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 11.25 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.4 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 405.53 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2971.47 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ChartMill assigns a fundamental rating of 4 / 10 to NARI.
ChartMill assigns a valuation rating of 2 / 10 to INARI MEDICAL INC (NARI). This can be considered as Overvalued.
INARI MEDICAL INC (NARI) has a profitability rating of 3 / 10.